Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa

Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary

Celyad appoints Graham Morrell as Vice-President of Investors Relations & Communication

Celyad appoints Graham Morrell as Vice-President of Investors Relations & Communication

Celyad appoints Dr. David Gilham as Vice-President of Research & Development

Celyad appoints Dr. David Gilham as Vice-President of Research & Development

Celyad will present its NKR-2 immuno-oncology clinical program at 2016 ASCO Annual Meeting

Celyad will present its NKR-2 immuno-oncology clinical program at 2016 ASCO Annual Meeting

Celyad appoints leading international Immuno-Oncology experts to Scientific Advisory Board

Celyad appoints leading international Immuno-Oncology experts to Scientific Advisory Board

Celyad announces collaboration with Institut Curie for the development of its immuno-oncology program NKR-T

Celyad announces collaboration with Institut Curie for the development of its immuno-oncology program NKR-T

Celyad to present at the Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day

Celyad to present at the Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day

Celyad to Host an Immuno-Oncology R&D Analyst Day on March 24th in New York City

Celyad to Host an Immuno-Oncology R&D Analyst Day on March 24th in New York City

Prof. William Wijns appointed to chair the scientific committee that will oversee the CHART-1 data analysis and dissemination plan

Prof. William Wijns appointed to chair the scientific committee that will oversee the CHART-1 data analysis and dissemination plan

Celyad appoints Dr. Richard Mountfield as Vice-President of Global Regulatory Affairs

Celyad appoints Dr. Richard Mountfield as Vice-President of Global Regulatory Affairs

Celyad announces the appointment of Dr. Jean-Pierre Latere as Head of the Regenerative Medicine and Medical Device Franchise

Celyad announces the appointment of Dr. Jean-Pierre Latere as Head of the Regenerative Medicine and Medical Device Franchise